BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33774472)

  • 1. Targeting of extracellular protein-protein interactions with macrocyclic peptides.
    Taguchi S; Suga H
    Curr Opin Chem Biol; 2021 Jun; 62():82-89. PubMed ID: 33774472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RaPID Platform for the Discovery of Pseudo-Natural Macrocyclic Peptides.
    Goto Y; Suga H
    Acc Chem Res; 2021 Sep; 54(18):3604-3617. PubMed ID: 34505781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection-based discovery of macrocyclic peptides for the next generation therapeutics.
    Morioka T; Loik ND; Hipolito CJ; Goto Y; Suga H
    Curr Opin Chem Biol; 2015 Jun; 26():34-41. PubMed ID: 25703142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and screening of vast libraries of natural product-like macrocyclic peptides using in vitro display technologies.
    Bashiruddin NK; Suga H
    Curr Opin Chem Biol; 2015 Feb; 24():131-8. PubMed ID: 25483262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Road Ahead for the Development of Macrocyclic Peptide Ligands.
    Passioura T
    Biochemistry; 2020 Jan; 59(2):139-145. PubMed ID: 31592645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A current perspective on applications of macrocyclic-peptide-based high-affinity ligands.
    Leenheer D; Ten Dijke P; Hipolito CJ
    Biopolymers; 2016 Nov; 106(6):889-900. PubMed ID: 27352774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facile Synthesis of Dimeric Thioether-Macrocyclic Peptides with Antibody-like Affinity against Plexin-B1.
    Bashiruddin NK; Matsunaga Y; Nagano M; Takagi J; Suga H
    Bioconjug Chem; 2018 Jun; 29(6):1847-1851. PubMed ID: 29714478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting intracellular protein-protein interactions with macrocyclic peptides.
    Buyanova M; Pei D
    Trends Pharmacol Sci; 2022 Mar; 43(3):234-248. PubMed ID: 34911657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein-Protein Interactions.
    Krüger DM; Glas A; Bier D; Pospiech N; Wallraven K; Dietrich L; Ottmann C; Koch O; Hennig S; Grossmann TN
    J Med Chem; 2017 Nov; 60(21):8982-8988. PubMed ID: 29028171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-Encoded Macrocyclic Peptide Library.
    Zhu Z; Shaginian A; Grady SC; Davie CP; Lind K; Pal S; Thansandote P; Simpson GL
    Methods Mol Biol; 2019; 2001():273-284. PubMed ID: 31134575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA Display Methods for the Discovery of Bioactive Macrocycles.
    Huang Y; Wiedmann MM; Suga H
    Chem Rev; 2019 Sep; 119(17):10360-10391. PubMed ID: 30395448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining Chemical Protein Synthesis and Random Nonstandard Peptides Integrated Discovery for Modulating Biological Processes.
    Saha A; Suga H; Brik A
    Acc Chem Res; 2023 Jul; 56(14):1953-1965. PubMed ID: 37312234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric Inhibition of a Semaphorin 4D Receptor Plexin B1 by a High-Affinity Macrocyclic Peptide.
    Matsunaga Y; Bashiruddin NK; Kitago Y; Takagi J; Suga H
    Cell Chem Biol; 2016 Nov; 23(11):1341-1350. PubMed ID: 27984026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro genetic code reprogramming and expansion to study protein function and discover macrocyclic peptide ligands.
    Richardson SL; Dods KK; Abrigo NA; Iqbal ES; Hartman MC
    Curr Opin Chem Biol; 2018 Oct; 46():172-179. PubMed ID: 30077877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating Protein-Protein Interactions by Cyclic and Macrocyclic Peptides. Prominent Strategies and Examples.
    González-Muñiz R; Bonache MÁ; Pérez de Vega MJ
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33467010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic and Macrocyclic Peptides as Chemical Tools To Recognise Protein Surfaces and Probe Protein-Protein Interactions.
    Cardote TA; Ciulli A
    ChemMedChem; 2016 Apr; 11(8):787-94. PubMed ID: 26563831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular signaling and gene expression profiles evoked by a bivalent macrocyclic peptide that serves as an artificial MET receptor agonist.
    Miao W; Sakai K; Ozawa N; Nishiuchi T; Suzuki Y; Ito K; Morioka T; Umitsu M; Takagi J; Suga H; Matsumoto K
    Sci Rep; 2018 Nov; 8(1):16492. PubMed ID: 30405161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic peptides can engage a single binding pocket through highly divergent modes.
    Patel K; Walport LJ; Walshe JL; Solomon PD; Low JKK; Tran DH; Mouradian KS; Silva APG; Wilkinson-White L; Norman A; Franck C; Matthews JM; Guss JM; Payne RJ; Passioura T; Suga H; Mackay JP
    Proc Natl Acad Sci U S A; 2020 Oct; 117(43):26728-26738. PubMed ID: 33046654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A macrocyclic peptide that serves as a cocrystallization ligand and inhibits the function of a MATE family transporter.
    Hipolito CJ; Tanaka Y; Katoh T; Nureki O; Suga H
    Molecules; 2013 Aug; 18(9):10514-30. PubMed ID: 23999725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo targeting of c-Met using a non-standard macrocyclic peptide in gastric carcinoma.
    Hwang DW; Bahng N; Ito K; Ha S; Kim MY; Lee E; Suga H; Lee DS
    Cancer Lett; 2017 Jan; 385():144-149. PubMed ID: 27810404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.